These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 32534564)

  • 1. Exosomes in Ischemic Stroke.
    Nozohouri S; Vaidya B; Abbruscato TJ
    Curr Pharm Des; 2020; 26(42):5533-5545. PubMed ID: 32534564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia-specific anti-RAGE exosomes for nose-to-brain delivery of anti-miR-181a oligonucleotide in an ischemic stroke model.
    Kim M; Lee Y; Lee M
    Nanoscale; 2021 Sep; 13(33):14166-14178. PubMed ID: 34477698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential Role of Exosomes in Ischemic Stroke Treatment.
    Jiang L; Chen W; Ye J; Wang Y
    Biomolecules; 2022 Jan; 12(1):. PubMed ID: 35053263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel brain targeted plasma exosomes enhance the neuroprotective efficacy of edaravone in ischemic stroke.
    Guo L; Pan J; Li F; Zhao L; Shi Y
    IET Nanobiotechnol; 2021 Feb; 15(1):107-116. PubMed ID: 34694723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role and therapeutic potential of exosomes in ischemic stroke.
    Li JY; Li QQ; Sheng R
    Neurochem Int; 2021 Dec; 151():105194. PubMed ID: 34582960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosome therapies improve outcome in rodents with ischemic stroke; meta-analysis.
    Cherian SG; Narayan SK; Arumugam M
    Brain Res; 2023 Mar; 1803():148228. PubMed ID: 36592803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in nanomedicines: a promising therapeutic strategy for ischemic cerebral stroke treatment.
    Li J; Xie F; Ma X
    Nanomedicine (Lond); 2024 Apr; 19(9):811-835. PubMed ID: 38445614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comprehensive overview of exosomes as drug delivery vehicles - endogenous nanocarriers for targeted cancer therapy.
    Johnsen KB; Gudbergsson JM; Skov MN; Pilgaard L; Moos T; Duroux M
    Biochim Biophys Acta; 2014 Aug; 1846(1):75-87. PubMed ID: 24747178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic application of exosomes in ischaemic stroke.
    Li Y; Tang Y; Yang GY
    Stroke Vasc Neurol; 2021 Sep; 6(3):483-495. PubMed ID: 33431513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of erythropoietin on neurogenesis after ischemic stroke.
    Zhang SJ; Luo YM; Wang RL
    J Integr Neurosci; 2020 Sep; 19(3):561-570. PubMed ID: 33070534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. State-of-the-art exosome loading and functionalization techniques for enhanced therapeutics: a review.
    Donoso-Quezada J; Ayala-Mar S; González-Valdez J
    Crit Rev Biotechnol; 2020 Sep; 40(6):804-820. PubMed ID: 32605394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface functionalized exosomes as targeted drug delivery vehicles for cerebral ischemia therapy.
    Tian T; Zhang HX; He CP; Fan S; Zhu YL; Qi C; Huang NP; Xiao ZD; Lu ZH; Tannous BA; Gao J
    Biomaterials; 2018 Jan; 150():137-149. PubMed ID: 29040874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosome-based delivery strategies for tumor therapy: an update on modification, loading, and clinical application.
    Yang Q; Li S; Ou H; Zhang Y; Zhu G; Li S; Lei L
    J Nanobiotechnology; 2024 Jan; 22(1):41. PubMed ID: 38281957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomes Secreted by the Cocultures of Normal and Oxygen-Glucose-Deprived Stem Cells Improve Post-stroke Outcome.
    Nalamolu KR; Venkatesh I; Mohandass A; Klopfenstein JD; Pinson DM; Wang DZ; Kunamneni A; Veeravalli KK
    Neuromolecular Med; 2019 Dec; 21(4):529-539. PubMed ID: 31077035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applications of Liposomal Drug Delivery Systems to Develop Neuroprotective Agents for the Treatment of Ischemic Stroke.
    Fukuta T; Ishii T; Asai T; Oku N
    Biol Pharm Bull; 2019; 42(3):319-326. PubMed ID: 30828062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondria as a therapeutic target for ischemic stroke.
    He Z; Ning N; Zhou Q; Khoshnam SE; Farzaneh M
    Free Radic Biol Med; 2020 Jan; 146():45-58. PubMed ID: 31704373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomes Engineering and Their Roles as Therapy Delivery Tools, Therapeutic Targets, and Biomarkers.
    Kučuk N; Primožič M; Knez Ž; Leitgeb M
    Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanomedicinal Strategies as Emerging Therapeutic Avenues to Treat and Manage Cerebral Ischemia.
    Fatima S; Quadri SN; Parveen S; Beg S; Barkat MA; Samim M; Abdin MZ; Ahmad FJ
    CNS Neurol Disord Drug Targets; 2021; 20(2):125-144. PubMed ID: 33138766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using exosomes, naturally-equipped nanocarriers, for drug delivery.
    Batrakova EV; Kim MS
    J Control Release; 2015 Dec; 219():396-405. PubMed ID: 26241750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic angiogenesis of exosomes for ischemic stroke.
    Manuel GE; Johnson T; Liu D
    Int J Physiol Pathophysiol Pharmacol; 2017; 9(6):188-191. PubMed ID: 29348795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.